货号:A244479
同义名:
奎宁单盐酸盐二水合物
/ Quinine HCl Dihydrate; Quinine(hydrochloride dihydrate)
Quinine HCl, a natural white crystalline alkaloid, is a K+ channel blocker with antipyretic (fever-reducing), antimalarial, analgesic (painkilling), anti-inflammatory properties.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Quinine Hydrochloride Dihydrate is a natural white crystalline alkaloid having antipyretic (fever-reducing), antimalarial, analgesic (painkilling), anti-inflammatory properties and a bitter taste. In patients with cerebral malaria receiving the standard dose of 10 mg/kg every eight hours, plasma quinine concentrations consistently exceeded 10 mg/liter, reaching a peak 60 +/- 25 hours (mean +/- 1 S.D.) after treatment was begun and then declining[3]. All field isolates exhibited higher IC50 values of CQ (chloroquine diphosphate), quinine hydrochloride dihydrate and DHA (dihydro-artemisinin) compared to reference strains. The resistance index of field isolates with respect to 3D7 ranged between 260.55 and 403.78 to CQ, 39.83 and 46.42 to quinine, and 2.98 and 4.16 to DHA[4]. In a multilevel Poisson regression model adjusted for sex, age, ADL(activities of daily living), smoking status, drinking status, number of medications used, use of medication for hypertension and diabetes and flow rate of saliva, subjects with low sensitivity (>0·003% quinine hydrochloride dihydrate) to bitter taste had a significant 1·70 times higher prevalence ratio (95% confident interval 1·04-2·80) for underweight compared with those with high sensitivity (0·0001% quinine hydrochloride dihydrate) [5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01289561 | Alcohol or Other Drugs Effects | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Behavioral Pharmacology Research Unit Baltimore, Maryland, United States, 21224 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.52mL 0.50mL 0.25mL |
12.60mL 2.52mL 1.26mL |
25.19mL 5.04mL 2.52mL |
CAS号 | 6119-47-7 |
分子式 | C20H29ClN2O4 |
分子量 | 396.91 |
SMILES Code | O[C@H](C1=CC=NC2=CC=C(OC)C=C12)[C@H]3[N@@]4C[C@H](C=C)[C@](CC4)([H])C3.[H]Cl.[H]O[H].[H]O[H] |
MDL No. | MFCD00151248 |
别名 | 奎宁单盐酸盐二水合物 ;Quinine HCl Dihydrate; Quinine(hydrochloride dihydrate) |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, room temperature |
溶解方案 |
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。
|
动物实验配方 |
PO 0.5% CMC-Na 30 mg/mL suspension |